Funder: DH | National Institute for Health Research (NIHR); doi: https://doi.org/10.13039/501100000272Funder: RCUK | Medical Research Council (MRC); doi: https://doi.org/10.13039/501100000265AbstractPeople with schizophrenia show higher risk for abdominal obesity than the general population, which could contribute to excess mortality. However, it is unclear whether this is driven by alterations in abdominal fat partitioning. Here, we test the hypothesis that individuals with schizophrenia show a higher proportion of visceral to total body fat measured using magnetic resonance imaging (MRI). We recruited 38 participants with schizophrenia and 38 healthy controls matched on age, sex, ethnicity, and body mass index. We found no significant dif...
Objective: Obesity associated with atypical antipsychotic medications is an important clinical issue...
Introduction: Antipsychotic medication and lifestyle factors are implicated in the high rates of obe...
We would like to thank Dr Moira Connolly, Professor Steve Lawrie and Dr Carol Robertson who, along w...
People with schizophrenia show higher risk for abdominal obesity than the general population, which ...
Schizophrenia is frequently associated with obesity, which is linked with neurostructural alteration...
Schizophrenia is frequently associated with obesity, which is linked with neurostructural alteration...
International audienceOBJECTIVE:Abdominal obesity was suggested to be a better predictor than Metabo...
Background: Metabolic syndrome (MetS) is a common problem in schizophrenia patients and associated w...
Although antipsychotic treatment often causes weight gain and lipid abnormalities, quantitative anal...
Background. Obesity seems to be very frequent among schizophrenics, partly due to psychotropic medic...
Background: Despite extensive clinical concern about rates of obesity in patients with schizophrenia...
Background: Hyperlipidemia and overweight are more common problems in schizophrenic patients. In sev...
Objective: Obesity associated with atypical antipsychotic medications is an important clinical issue...
Introduction: Antipsychotic medication and lifestyle factors are implicated in the high rates of obe...
We would like to thank Dr Moira Connolly, Professor Steve Lawrie and Dr Carol Robertson who, along w...
People with schizophrenia show higher risk for abdominal obesity than the general population, which ...
Schizophrenia is frequently associated with obesity, which is linked with neurostructural alteration...
Schizophrenia is frequently associated with obesity, which is linked with neurostructural alteration...
International audienceOBJECTIVE:Abdominal obesity was suggested to be a better predictor than Metabo...
Background: Metabolic syndrome (MetS) is a common problem in schizophrenia patients and associated w...
Although antipsychotic treatment often causes weight gain and lipid abnormalities, quantitative anal...
Background. Obesity seems to be very frequent among schizophrenics, partly due to psychotropic medic...
Background: Despite extensive clinical concern about rates of obesity in patients with schizophrenia...
Background: Hyperlipidemia and overweight are more common problems in schizophrenic patients. In sev...
Objective: Obesity associated with atypical antipsychotic medications is an important clinical issue...
Introduction: Antipsychotic medication and lifestyle factors are implicated in the high rates of obe...
We would like to thank Dr Moira Connolly, Professor Steve Lawrie and Dr Carol Robertson who, along w...